{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:54:53Z","timestamp":1790139293943,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.radonc.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T17:47:09Z","timestamp":1455904029000},"page":"257-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent \u2013 A population based study from the DAHANCA group"],"prefix":"10.1016","volume":"118","author":[{"given":"Nina Munk","family":"Lyhne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus A.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2476-1037","authenticated-orcid":false,"given":"Elo","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Primdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth J.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte R.","family":"B\u00f8je","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni R.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.02.006_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0167-8140(94)90410-3","article-title":"Controversies in the management of laryngeal cancer: results of an international survey of patterns of care","volume":"31","author":"O\u2019Sullivan","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002027.pub2","article-title":"Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer","author":"Warner","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2016.02.006_b0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hed.21295","article-title":"Larynx preservation and survival trends: should there be concern?","volume":"32","author":"Forastiere","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hed.21294","article-title":"Reexamining the treatment of advanced laryngeal cancer","volume":"32","author":"Olsen","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/lary.21226","article-title":"What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility?","volume":"121","author":"Higgins","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2016.02.006_b0030","article-title":"Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: a systematic review","author":"Yoo","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijrobp.2014.06.032","article-title":"Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy","volume":"90","author":"Aaltonen","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.02.006_b0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/hed.23603","article-title":"Quality of life and voice assessment in patients with early-stage glottic cancer","volume":"37","author":"Arias","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0045","first-page":"49","article-title":"Functional outcomes and laryngectomy-free survival after transoral CO2 laser microsurgery for stage 1 and 2 glottic carcinoma magdalena","volume":"40","author":"Kujath","year":"2011","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2016.02.006_b0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ejso.2007.06.008","article-title":"Challenging a dogma\u2013surgery yields superior long-term results for T1a squamous cell carcinoma of the glottic larynx compared to radiotherapy","volume":"34","author":"Thurnher","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hed.21027","article-title":"Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma","volume":"31","author":"Schrijvers","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hed.1120","article-title":"Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy","volume":"23","author":"Bron","year":"2001","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/hed.20852","article-title":"Clinical outcome of T1 glottic carcinoma since the introduction of endoscopic CO2 laser surgery as treatment option","volume":"30","author":"Sjogren","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00405-009-1135-0","article-title":"Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma?","volume":"267","author":"Mahler","year":"2010","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.radonc.2016.02.006_b0075","article-title":"Laryngeal cancer in Finland: a 5-year follow-up study of 366 patients","author":"Haapaniemi","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2016.02.006_b0085","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2016.02.006_b0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"94","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site","volume":"100","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mlg.0000236095.97947.26","article-title":"Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival","volume":"116","author":"Hoffman","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2016.02.006_b0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/02841868709092970","article-title":"Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma. A study initiated by the Danish Society of Head and Neck Cancer","volume":"26","author":"Hansen","year":"1987","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0110","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0360-3016(89)90917-6","article-title":"Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study","volume":"16","author":"Overgaard","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.02.006_b0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.radonc.2015.07.004","article-title":"The DAHANCA 6 randomized trial: effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma","volume":"117","author":"Lyhne","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0120","first-page":"P291","article-title":"DAHANCA 9 \u2013 a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck","volume":"49","author":"Evensen","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2016.02.006_b0125","first-page":"1","article-title":"Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study","author":"Bentzen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0130","unstructured":"Lyhne NM, Johansen J, Kristensen C, Andersen E, Primdahl H, Andersen L, et al. Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011 \u2013 a report from the DAHANCA group. Re-Accepted for publication in Eur J Cancer."},{"key":"10.1016\/j.radonc.2016.02.006_b0135","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/1097-0142(19880601)61:11<2310::AID-CNCR2820611127>3.0.CO;2-X","article-title":"TNM classification of malignant tumors. A comparison between the new (1987) and the old editions","volume":"61","author":"Sobin","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.02.006_b0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","article-title":"A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5\u201385","volume":"46","author":"Overgaard","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0145","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.02.006_b0150","first-page":"1627","article-title":"Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002","volume":"2013","author":"Lyhne","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2016.02.006_b0155","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hed.20071","article-title":"The impact of computed tomography on pretherapeutic staging in patients with laryngeal cancer: demonstration of the will Rogers\u2019 phenomenon","volume":"26","author":"Champion","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/1097-0142(20010115)91:2<394::AID-CNCR1014>3.0.CO;2-J","article-title":"The role of computed tomography in the T classification of laryngeal carcinoma","volume":"91","author":"Barbera","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.02.006_b0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-8140(02)00118-4","article-title":"Glottic carcinoma \u2013 patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients","volume":"63","author":"Johansen","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/028418698430467","article-title":"Lymph node metastases from laryngeal and pharyngeal carcinomas\u2013calculation of burden of metastasis and its impact on prognosis","volume":"37","author":"Jakobsen","year":"1998","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2013.12.027","article-title":"Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer","volume":"89","author":"Beitler","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.02.006_b0180","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM199009203231205","article-title":"Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck","volume":"323","author":"Hong","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2016.02.006_b0185","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/lary.24719","article-title":"Incidence of second metachronous head and neck cancers: Population-based outcomes over 25years","volume":"124","author":"Tiwana","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2016.02.006_b0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.02.006_b0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1470-2045(10)70072-3","article-title":"Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial","volume":"11","author":"Overgaard","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-8140(97)01944-0","article-title":"A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer","volume":"43","author":"Jackson","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(97)00079-0","article-title":"Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial","volume":"44","author":"Horiot","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2012.01.002","article-title":"Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer","volume":"103","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2004.12.018","article-title":"The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study","volume":"74","author":"Eriksen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0225","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/cncr.20181","article-title":"Management of T1\u2013T2 glottic carcinomas","volume":"100","author":"Mendenhall","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.02.006_b0230","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","article-title":"T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. - PubMed - NCBI","author":"Chera","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.02.006_b0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0360-3016(01)01812-0","article-title":"Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer","volume":"52","author":"Haugen","year":"2002","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0240","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ijrobp.2005.05.018","article-title":"Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease","volume":"63","author":"Cellai","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.02.006_b0245","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hed.23641","article-title":"Accelerated radiotherapy for T1 to T2 glottic cancer","volume":"37","author":"Motegi","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/02841868809090334","article-title":"Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx","volume":"27","author":"Overgaard","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0255","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2014.04.041","article-title":"Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)","volume":"89","author":"Trotti","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.02.006_b0260","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/02841860310017595","article-title":"Laryngeal carcinoma\u2013multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy","volume":"42","author":"Johansen","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0265","unstructured":"DAHANCA. DAHANCA guidelines n.d. https:\/\/www.dahanca.oncology.dk\/Brows_Web_Guidelines (accessed December 7, 2015)."},{"key":"10.1016\/j.radonc.2016.02.006_b0270","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0275","doi-asserted-by":"crossref","DOI":"10.3747\/co.22.2361","article-title":"Secular trends in the survival of patients with laryngeal carcinoma, 1995\u20132007","volume":"22","author":"Macneil","year":"2015","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0280","doi-asserted-by":"crossref","DOI":"10.1002\/lary.25338","article-title":"Differences in survival outcome between stage I and stage II glottic cancer: a SEER-based analysis","author":"Chen","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2016.02.006_b0285","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/coa.12139","article-title":"Radiotherapy for T1\u20132N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients","volume":"38","author":"Al-Mamgani","year":"2013","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.radonc.2016.02.006_b0290","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0360-3016(86)90058-1","article-title":"Primary radiotherapy of larynx and pharynx carcinoma\u2013an analysis of some factors influencing local control and survival","volume":"12","author":"Overgaard","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.02.006_b0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/0284186X.2012.742964","article-title":"The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database","volume":"52","author":"B\u00f8je","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0300","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.radonc.2013.11.009","article-title":"Evaluation of comorbidity in 9388 head and neck cancer patients: A national cohort study from the DAHANCA database","volume":"110","author":"B\u00f8je","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0305","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1728::AID-CNCR29>3.0.CO;2-7","article-title":"Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States","volume":"88","author":"Skarsgard","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.02.006_b0310","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12094-012-0787-1","article-title":"Laryngeal cancer survival in Zaragoza (Spain): a population-based study","volume":"14","author":"Bezerra De Souza","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2016.02.006_b0315","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/hed.21720","article-title":"Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck","volume":"34","author":"Landis","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.02.006_b0320","article-title":"Trends in treatment and survival for advanced laryngeal cancer: a 20-year population-based study in The Netherlands. \u2013 PubMed \u2013 NCBI","author":"Timmermans","year":"2015","journal-title":"Head Neck"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T13:30:10Z","timestamp":1718371810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0167814016000645"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.02.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent \u2013 A population based study from the DAHANCA group","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}